Chemometec A/S Stock | CHEMM.CO | DK0060055861 | A0MS80

Date	Chemometec A/S Price
9/6/2024	402.00 undefined
9/5/2024	375.60 undefined
9/4/2024	367.00 undefined
9/3/2024	363.00 undefined
9/2/2024	373.00 undefined
8/30/2024	374.60 undefined
8/29/2024	380.20 undefined
8/28/2024	372.40 undefined
8/27/2024	382.00 undefined
8/26/2024	380.60 undefined
8/23/2024	393.60 undefined
8/22/2024	376.80 undefined
8/21/2024	375.00 undefined
8/20/2024	381.00 undefined
8/19/2024	388.60 undefined
8/16/2024	385.00 undefined
8/15/2024	391.00 undefined
8/14/2024	382.20 undefined
8/13/2024	378.00 undefined
8/12/2024	378.60 undefined

Date	Chemometec A/S Revenue	Chemometec A/S EBIT	Chemometec A/S Net Income
2026e	467.62 M undefined	192.61 M undefined	154.15 M undefined
2025e	454.75 M undefined	197.25 M undefined	156.93 M undefined
2024e	436.72 M undefined	208.06 M undefined	161.68 M undefined
2023	444.4 M undefined	230.64 M undefined	178.67 M undefined
2022	428.39 M undefined	202.76 M undefined	159.47 M undefined
2021	281.13 M undefined	116.85 M undefined	88.35 M undefined
2020	214.1 M undefined	77.18 M undefined	59.16 M undefined
2019	175.51 M undefined	54.03 M undefined	41.85 M undefined
2018	112.69 M undefined	24.28 M undefined	18.22 M undefined
2017	90.33 M undefined	10.42 M undefined	7.49 M undefined
2016	85.23 M undefined	15.9 M undefined	10.48 M undefined
2015	61.24 M undefined	5.83 M undefined	7.95 M undefined
2014	45.2 M undefined	1.6 M undefined	1.2 M undefined
2013	41.4 M undefined	1.5 M undefined	300,000 undefined
2012	39.2 M undefined	-11.5 M undefined	-9.9 M undefined
2011	37.2 M undefined	800,000 undefined	100,000 undefined
2010	32.6 M undefined	-1.6 M undefined	-3.7 M undefined
2009	32.1 M undefined	2.1 M undefined	4.6 M undefined
2008	44.8 M undefined	14.8 M undefined	13.2 M undefined
2007	22.3 M undefined	1.4 M undefined	1.1 M undefined
2006	14.6 M undefined	800,000 undefined	4.1 M undefined
2005	13.9 M undefined	100,000 undefined	-1 M undefined

	Revenue	EBIT	Net Income
2005	13.9 M DKK	100,000 DKK	-1 M DKK
2006	14.6 M DKK	800,000 DKK	4.1 M DKK
2007	22.3 M DKK	1.4 M DKK	1.1 M DKK
2008	44.8 M DKK	14.8 M DKK	13.2 M DKK
2009	32.1 M DKK	2.1 M DKK	4.6 M DKK
2010	32.6 M DKK	-1.6 M DKK	-3.7 M DKK
2011	37.2 M DKK	800,000 DKK	100,000 DKK
2012	39.2 M DKK	-11.5 M DKK	-9.9 M DKK
2013	41.4 M DKK	1.5 M DKK	300,000 DKK
2014	45.2 M DKK	1.6 M DKK	1.2 M DKK
2015	61.24 M DKK	5.83 M DKK	7.95 M DKK
2016	85.23 M DKK	15.9 M DKK	10.48 M DKK
2017	90.33 M DKK	10.42 M DKK	7.49 M DKK
2018	112.69 M DKK	24.28 M DKK	18.22 M DKK
2019	175.51 M DKK	54.03 M DKK	41.85 M DKK
2020	214.1 M DKK	77.18 M DKK	59.16 M DKK
2021	281.13 M DKK	116.85 M DKK	88.35 M DKK
2022	428.39 M DKK	202.76 M DKK	159.47 M DKK
2023	444.4 M DKK	230.64 M DKK	178.67 M DKK
2024e	436.72 M DKK	208.06 M DKK	161.68 M DKK
2025e	454.75 M DKK	197.25 M DKK	156.93 M DKK
2026e	467.62 M DKK	192.61 M DKK	154.15 M DKK

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.9	17.8	25.3	5.4	11.8	8.9	7.1	8.7	9.1	6.9	10.89	14.12	12.4	9.78	98.2	96.94	150.11	209.03	316.57
1.9	2.1	4.2	9.3	5.3	3.4	4	4.7	5.4	5.4	7.36	15.08	14.62	17.67	34.71	35.44	50.64	65.87	54.83
0.1	0.4	1.3	11	3.2	3.3	1.3	0.5	1.1	1.8	4.36	0.35	0.06	1.52	1.32	7.84	12.01	3.67	4.91
2.3	2.8	4.2	5.5	6.8	7.9	7.6	7.9	7.4	8.1	6.48	7.54	13.31	16.84	19.52	25.11	30.11	66.79	112.64
0	0	0.2	0	0.1	0	0	0	0	0	0.18	0.43	0.63	1.01	1.09	2.93	1.49	7.58	3.71
5.2	23.1	35.2	31.2	27.2	23.5	20	21.8	23	22.2	29.27	37.53	41.02	46.81	154.83	168.26	244.36	352.94	492.66
2.1	1.5	2.9	4	5.4	4.6	3.3	1.9	1.1	1.7	5.5	25.47	26.42	28.94	38.15	43.36	42.5	74.78	82.69
500	500	600	500	500	500	600	400	400	500	843	19	46	46	111	111	172	303	318
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.49	3.67	4.91
0.5	2.3	8.3	17.6	27.5	31.6	34.5	22.1	23.3	24.1	23.62	26.21	30.05	38.21	45.13	51.38	57.88	67.4	79.66
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	4.4	4.4	2.7	4.6	2.5	2.4	3.7	3	3	4.24	1.15	0.08	0	0	0	0	5.85	2.65
3.1	8.7	16.2	24.8	38	39.2	40.8	28.1	27.8	29.3	34.2	52.85	56.6	67.19	83.39	94.85	114.04	152.01	170.23
8.3	31.8	51.4	56	65.2	62.7	60.8	49.9	50.8	51.5	63.47	90.38	97.62	114	238.21	263.12	358.4	504.94	662.89

1.3	1.6	17.4	17.4	17.4	17.4	17.4	17.4	17.4	17.4	17.4	17.4	17.4	17.4	17.4	17.4	17.4	17.4	17.4
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-12.2	14.9	21.9	34.3	38.9	35.2	35.3	25.5	25.8	27.1	28.95	39.45	46.58	55.23	108.29	159.23	177.96	339.78	411.21
0	0	0	0	0	0	0	0	0	0	0	0	0.39	0.38	47.65	26.12	69.61	0.03	104.43
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-10.9	16.5	39.3	51.7	56.3	52.6	52.7	42.9	43.2	44.5	46.35	56.85	64.38	73.01	173.34	202.75	264.98	357.21	533.04
1.2	0.8	2.2	2.5	1.3	1.8	1.2	1	1.9	1.4	3.48	5.39	4.89	7.26	9.71	8.43	8.71	17.02	17.55
1.5	1.6	1.2	1.8	2.9	3.5	2.7	2.7	3.1	3.7	5.81	5.32	6.01	8.9	20.11	17.52	21.25	30.18	8.2
0	0	0	0	0	0	0	0	0	0	0	0.35	0.28	0	6.37	20.63	61.82	118.42	98.12
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.2	2.2	2.8	0	0.6	0.7	0.7	0.8	0.8	0.8	2.6	4.88	9.91	1.7	18.8	1.1	1.45	1.93	3.52
3.9	4.6	6.2	4.3	4.8	6	4.6	4.5	5.8	5.9	11.88	15.94	21.08	17.87	54.98	47.68	93.22	167.55	127.4
14.9	10.7	5.9	0	4.1	4.1	3.4	2.6	1.8	0.9	5.23	17.35	11.95	18.4	0	1.19	0.91	4.86	3.64
0	0	0	0	0	0	0	0	0	0	0	0	0	4.42	9.3	10.43	5.76	0	0
0.4	0.3	0.1	0	0	0	0	0	0	0	0	0.24	0.22	0.29	0.59	1.07	1.29	1.83	2.1
15.3	11	6	0	4.1	4.1	3.4	2.6	1.8	0.9	5.23	17.59	12.16	23.11	9.89	12.69	7.96	6.69	5.74
19.2	15.6	12.2	4.3	8.9	10.1	8	7.1	7.6	6.8	17.12	33.53	33.24	40.99	64.87	60.36	101.18	174.24	133.14
8.3	32.1	51.5	56	65.2	62.7	60.7	50	50.8	51.3	63.47	90.38	97.62	114	238.22	263.12	366.16	531.45	666.18

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0	0	1	14	2	-1	0	-11	1	1	5	15	10	24	54	77	116	202	230
0	1	0	1	2	6	7	20	6	5	5	6	5	5	10	15	19	20	20
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-1	-1	-2	-14	10	1	0	0	0	-1	1	-5	-6	-4	-6	-20	-27	-46	-96
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11	14	-4
0	0	0	0	0	0	0	0	0	0	0	2	1	0	0	1	0	1	1
0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	11	16	27	57
0	0	0	1	15	6	7	8	7	5	13	17	9	25	58	72	107	176	154
-1	-2	-8	-11	-13	-9	-8	-6	-6	-7	-8	-29	-10	-16	-27	-26	-24	-55	-40
-1	-2	-8	-11	-13	-9	-8	-6	-6	-7	-9	-28	-10	-16	-27	-26	-24	-56	-40
0	0	0	0	0	0	0	0	0	0	0	1,000	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
3	-1	-2	-8	4	0	0	0	0	0	4	12	0	-6	0	-19	0	-1	-2
0	20	18	0	0	0	0	0	0	0	-6	0	0	-9	58	318	0	0	0
3	18	16	-9	4	0	0	0	0	0	-2	12	0	-7	57	-46	-26	-69	-2
0	0	0	0	0	0	0	0	0	0	0	0	0	7	0	11	0	1	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-356	-26	-69	0
1	16	7	-19	6	-2	-1	1	0	-2	2	0	-1	0	89	-1	53	58	107
-1.93	-1.86	-8.94	-10.32	1.72	-3.07	-1	2.18	1.17	-1.45	4.41	-12.69	-0.83	8.97	31.24	45.28	83.28	120.94	113.33
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Chemometec A/S Gross margin	Chemometec A/S Profit margin	Chemometec A/S EBIT margin	Chemometec A/S Profit margin
2026e	78.91 %	41.19 %	32.97 %
2025e	78.91 %	43.38 %	34.51 %
2024e	78.91 %	47.64 %	37.02 %
2023	78.91 %	51.9 %	40.2 %
2022	80.06 %	47.33 %	37.23 %
2021	81.78 %	41.57 %	31.43 %
2020	78.56 %	36.05 %	27.63 %
2019	76.65 %	30.78 %	23.84 %
2018	70.3 %	21.55 %	16.16 %
2017	66.47 %	11.53 %	8.29 %
2016	65.48 %	18.65 %	12.3 %
2015	63.46 %	9.52 %	12.98 %
2014	65.04 %	3.54 %	2.65 %
2013	66.43 %	3.62 %	0.72 %
2012	66.58 %	-29.34 %	-25.26 %
2011	68.82 %	2.15 %	0.27 %
2010	64.42 %	-4.91 %	-11.35 %
2009	61.99 %	6.54 %	14.33 %
2008	69.42 %	33.04 %	29.46 %
2007	56.5 %	6.28 %	4.93 %
2006	58.9 %	5.48 %	28.08 %
2005	51.08 %	0.72 %	-7.19 %

	Gross margin	EBIT margin	Profit margin
2005	51.08 %	0.72 %	-7.19 %
2006	58.9 %	5.48 %	28.08 %
2007	56.5 %	6.28 %	4.93 %
2008	69.42 %	33.04 %	29.46 %
2009	61.99 %	6.54 %	14.33 %
2010	64.42 %	-4.91 %	-11.35 %
2011	68.82 %	2.15 %	0.27 %
2012	66.58 %	-29.34 %	-25.26 %
2013	66.43 %	3.62 %	0.72 %
2014	65.04 %	3.54 %	2.65 %
2015	63.46 %	9.52 %	12.98 %
2016	65.48 %	18.65 %	12.3 %
2017	66.47 %	11.53 %	8.29 %
2018	70.3 %	21.55 %	16.16 %
2019	76.65 %	30.78 %	23.84 %
2020	78.56 %	36.05 %	27.63 %
2021	81.78 %	41.57 %	31.43 %
2022	80.06 %	47.33 %	37.23 %
2023	78.91 %	51.9 %	40.2 %
2024e	78.91 %	47.64 %	37.02 %
2025e	78.91 %	43.38 %	34.51 %
2026e	78.91 %	41.19 %	32.97 %

Date	Chemometec A/S Sales per Share	Chemometec A/S EBIT per share	Chemometec A/S Earnings per Share
2026e	26.87 undefined	0 undefined	8.86 undefined
2025e	26.13 undefined	0 undefined	9.02 undefined
2024e	25.1 undefined	0 undefined	9.29 undefined
2023	25.54 undefined	13.25 undefined	10.27 undefined
2022	24.62 undefined	11.65 undefined	9.16 undefined
2021	16.15 undefined	6.71 undefined	5.08 undefined
2020	12.7 undefined	4.58 undefined	3.51 undefined
2019	11.28 undefined	3.47 undefined	2.69 undefined
2018	7.26 undefined	1.57 undefined	1.17 undefined
2017	5.76 undefined	0.66 undefined	0.48 undefined
2016	5.44 undefined	1.01 undefined	0.67 undefined
2015	3.91 undefined	0.37 undefined	0.51 undefined
2014	2.6 undefined	0.09 undefined	0.07 undefined
2013	2.38 undefined	0.09 undefined	0.02 undefined
2012	2.25 undefined	-0.66 undefined	-0.57 undefined
2011	2.14 undefined	0.05 undefined	0.01 undefined
2010	1.87 undefined	-0.09 undefined	-0.21 undefined
2009	1.84 undefined	0.12 undefined	0.26 undefined
2008	2.57 undefined	0.85 undefined	0.76 undefined
2007	1.38 undefined	0.09 undefined	0.07 undefined
2006	0.86 undefined	0.05 undefined	0.24 undefined
2005	0.82 undefined	0.01 undefined	-0.06 undefined

	Sales per Share	EBIT per share	Earnings per Share
2005	0.82 DKK	0.01 DKK	-0.06 DKK
2006	0.86 DKK	0.05 DKK	0.24 DKK
2007	1.38 DKK	0.09 DKK	0.07 DKK
2008	2.57 DKK	0.85 DKK	0.76 DKK
2009	1.84 DKK	0.12 DKK	0.26 DKK
2010	1.87 DKK	-0.09 DKK	-0.21 DKK
2011	2.14 DKK	0.05 DKK	0.01 DKK
2012	2.25 DKK	-0.66 DKK	-0.57 DKK
2013	2.38 DKK	0.09 DKK	0.02 DKK
2014	2.6 DKK	0.09 DKK	0.07 DKK
2015	3.91 DKK	0.37 DKK	0.51 DKK
2016	5.44 DKK	1.01 DKK	0.67 DKK
2017	5.76 DKK	0.66 DKK	0.48 DKK
2018	7.26 DKK	1.57 DKK	1.17 DKK
2019	11.28 DKK	3.47 DKK	2.69 DKK
2020	12.7 DKK	4.58 DKK	3.51 DKK
2021	16.15 DKK	6.71 DKK	5.08 DKK
2022	24.62 DKK	11.65 DKK	9.16 DKK
2023	25.54 DKK	13.25 DKK	10.27 DKK
2024e	25.1 DKK	0 DKK	9.29 DKK
2025e	26.13 DKK	0 DKK	9.02 DKK
2026e	26.87 DKK	0 DKK	8.86 DKK

	Number of stocks
2005	17 M Aktien
2006	17 M Aktien
2007	16.2 M Aktien
2008	17.4 M Aktien
2009	17.4 M Aktien
2010	17.4 M Aktien
2011	17.4 M Aktien
2012	17.4 M Aktien
2013	17.4 M Aktien
2014	17.4 M Aktien
2015	15.67 M Aktien
2016	15.67 M Aktien
2017	15.67 M Aktien
2018	15.52 M Aktien
2019	15.56 M Aktien
2020	16.86 M Aktien
2021	17.4 M Aktien
2022	17.4 M Aktien
2023	17.4 M Aktien
2024e	17.4 M Aktien
2025e	17.4 M Aktien
2026e	17.4 M Aktien

Date	Chemometec A/S Dividend
2026e	2.62 undefined
2025e	2.41 undefined
2024e	3.45 undefined
2023	6 undefined
2021	4 undefined
2020	14.5 undefined
2019	7.5 undefined

	Dividend	Dividend (Estimate)
2005	0 DKK	0 DKK
2006	0 DKK	0 DKK
2007	0 DKK	0 DKK
2008	0 DKK	0 DKK
2009	0 DKK	0 DKK
2010	0 DKK	0 DKK
2011	0 DKK	0 DKK
2012	0 DKK	0 DKK
2013	0 DKK	0 DKK
2014	0 DKK	0 DKK
2015	0 DKK	0 DKK
2016	0 DKK	0 DKK
2017	0 DKK	0 DKK
2018	0 DKK	0 DKK
2019	7.5 DKK	0 DKK
2020	14.5 DKK	0 DKK
2021	4 DKK	0 DKK
2022	0 DKK	0 DKK
2023	6 DKK	0 DKK
2024e	0 DKK	3.45 DKK
2025e	0 DKK	2.41 DKK
2026e	0 DKK	2.62 DKK

Date	Chemometec A/S Payout ratio
2026e	226.21 %
2025e	233.89 %
2024e	195.11 %
2023	249.62 %
2022	256.93 %
2021	78.79 %
2020	413.16 %
2019	278.86 %
2018	256.93 %
2017	256.93 %
2016	256.93 %
2015	256.93 %
2014	256.93 %
2013	256.93 %
2012	256.93 %
2011	256.93 %
2010	256.93 %
2009	256.93 %
2008	256.93 %
2007	256.93 %
2006	256.93 %
2005	256.93 %

	Payout ratio
2005	256.93 %
2006	256.93 %
2007	256.93 %
2008	256.93 %
2009	256.93 %
2010	256.93 %
2011	256.93 %
2012	256.93 %
2013	256.93 %
2014	256.93 %
2015	256.93 %
2016	256.93 %
2017	256.93 %
2018	256.93 %
2019	278.86 %
2020	413.16 %
2021	78.79 %
2022	256.93 %
2023	249.62 %
2024e	195.11 %
2025e	233.89 %
2026e	226.21 %

%	Name	Stocks	Change	Date
6.24623 %	Swedbank Robur Fonder AB	1,087,000	-36,583	2/29/2024
5.06330 %	Invesco Advisers, Inc.	881,141	61,945	5/16/2023
4.05530 %	SEB Asset Management (Denmark)	705,724	-2,309	2/29/2024
3.56045 %	Handelsbanken Kapitalförvaltning AB	619,607	-107,247	3/31/2024
2.99210 %	SEB Investment Management AB	520,701	-3,234	2/29/2024
2.62058 %	Fidelity Management & Research Company LLC	456,046	266	2/29/2024
2.59728 %	The Vanguard Group, Inc.	451,991	1,886	3/31/2024
2.36441 %	Norges Bank Investment Management (NBIM)	411,466	1,605	12/31/2023
2.18359 %	TIN Fonder	380,000	0	2/28/2023
13.47998 %	BlackRock Investment Management (UK) Ltd.	2,345,854	160,103	4/9/2024
1.89963 %	Berenberg Bank (Asset Management)	330,583	260	1/31/2024
1.40833 %	Didner & Gerge Fonder AB	245,085	-99,144	12/31/2023
1.39492 %	Montanaro Asset Management Limited	242,751	-27,239	3/31/2024
1.37890 %	BlackRock Institutional Trust Company, N.A.	239,963	2,682	3/31/2024
1.04009 %	Dimensional Fund Advisors, L.P.	181,002	0	3/31/2024
0.92411 %	PensionDanmark A/S	160,818	-270,822	8/31/2023
0.86195 %	ODIN Forvaltning AS	150,000	0	2/29/2024
0.68976 %	Capital Research Global Investors	120,036	0	3/31/2024
0.58841 %	Danske Bank Asset Management	102,398	786	2/29/2024
0.47974 %	Celina Fondförvaltning AB	83,487	0	12/31/2023
0.36651 %	Schroder Investment Management Ltd. (SIM)	63,782	0	12/31/2023
0.26824 %	BlackRock Advisors (UK) Limited	46,680	-364	3/31/2024
0.20687 %	Schroder Investment Management (Europe) S.A.	36,000	0	12/31/2023
0.17483 %	Charles Schwab Investment Management, Inc.	30,424	0	3/31/2024
0.13962 %	Mellon Investments Corporation	24,297	-5	3/31/2024
0.10723 %	E.Öhman J:or Fonder AB	18,661	-2,136	2/29/2024
0.09930 %	California State Teachers Retirement System	17,281	440	6/30/2023
0.09510 %	Fundamental Fondsmæglerselskab A/S	16,549	-1,086	9/30/2023
0.09429 %	DWS Investment GmbH	16,408	712	2/29/2024
0.09223 %	State Street Global Advisors (US)	16,050	0	3/31/2024
0.07815 %	Deka Investment GmbH	13,600	-9,000	4/30/2023
0.07503 %	Nuveen LLC	13,057	0	3/31/2024
0.07052 %	Dimensional Fund Advisors, Ltd.	12,273	803	1/31/2024
0.06896 %	Ålandsbanken Asset Management Ab	12,000	0	2/29/2024
0.06821 %	Norron Asset Management AB	11,871	-1,400	2/29/2024
0.06162 %	Geode Capital Management, L.L.C.	10,723	0	2/29/2024
0.06086 %	Healthinvest Partners AB	10,592	2,350	2/29/2024
0.05613 %	KLP Fondsforvaltning AS	9,768	307	2/29/2024
0.05030 %	BI Asset Management Fondsmæglerselskab A/S	8,754	1,881	2/29/2024
0.04715 %	Credit Suisse Funds AG	8,206	0	2/29/2024
0.04322 %	Russell Investments Limited	7,522	109	2/29/2024
0.03933 %	PP Capital Asset Management Fondsmæglerselskab A/S	6,844	0	2/29/2024
0.03867 %	Case Kapitalförvaltning AB	6,729	6,729	12/31/2023
0.03532 %	American Century Investment Management, Inc.	6,146	60	3/31/2024
0.03483 %	Mediolanum International Funds Limited	6,061	0	12/31/2023
0.02900 %	State Street Global Advisors Ireland Limited	5,047	-451	3/31/2024
0.02869 %	UBS Asset Management (UK) Ltd.	4,993	0	2/29/2024
0.02847 %	BlackRock Asset Management Canada Limited	4,954	0	3/31/2024
0.02835 %	Florida State Board of Administration	4,933	390	9/30/2022
0.02825 %	Northern Trust Global Investments Limited	4,917	1,131	12/31/2023
0.02035 %	Mercer Global Investments Management Ltd	3,542	0	3/31/2024
0.01880 %	Irish Life Investment Managers Ltd.	3,272	0	3/31/2024
0.01818 %	SEI Investments Management Corporation	3,163	-3,284	3/31/2024
0.01752 %	Syquant Capital S.A.S	3,049	-209	3/31/2023
0.01743 %	Vanguard Investments Australia Ltd.	3,033	-2	2/29/2024
0.01736 %	DNB Asset Management AS	3,021	3,021	2/29/2024
0.01692 %	Boston Partners	2,945	751	2/29/2024
0.01681 %	Momentum Global Investment Management Limited	2,925	0	8/31/2022
0.01622 %	Zürcher Kantonalbank (Asset Management)	2,822	0	1/31/2024
0.01315 %	Trillium SA	2,289	-1,094	6/30/2023
0.01142 %	BCGE Asset Management	1,987	45	3/31/2024
0.01111 %	Sydbank	1,934	52	2/29/2024
0.00862 %	FOCUS Asset Management GMBH	1,500	0	1/31/2024
0.00842 %	DFA Australia Ltd.	1,465	707	12/31/2023
0.00775 %	Legal & General Investment Management Ltd.	1,348	0	2/29/2024
0.00622 %	Amundi Asset Management, SAS	1,083	-136	3/31/2024
0.00542 %	Nykredit Bank AS	943	0	2/29/2024
0.00528 %	Pictet Asset Management Ltd.	919	0	11/30/2023
0.00518 %	Northern Trust Investments, Inc.	902	0	3/31/2024
0.00380 %	UBS Asset Management (Switzerland)	662	0	1/31/2024
0.00290 %	Vanguard Global Advisers LLC	504	13	3/31/2024
0.00210 %	Indecap AB	365	0	3/31/2024
0.00070 %	PineBridge Investments LLC	122	0	9/30/2022
0.00065 %	Dimensional Fund Advisors Canada ULC	113	0	11/30/2023
0.00021 %	Man Investments Inc	37	9	1/31/2024
0.00010 %	Man Investments, Ltd.	18	5	1/31/2024
0.00003 %	MLC Asset Management	5	0	8/31/2022
0.00001 %	MLC Investments Limited	2	0	8/31/2022
0 %	Falcon Invest A/S	0	-1,919	9/30/2023
0 %	Hargreaves Lansdown Fund Managers Ltd.	0	-5,090	9/30/2022
0 %	DWS Investments UK Limited	0	-10,631	8/31/2023
0 %	Dr. Bauer & Co. Vermögensmanagement GmbH	0	-1,900	12/31/2023
0 %	BNP Paribas Asset Management UK Limited	0	-3,151	1/31/2023
0 %	Abante Asesores Gestión, S.G.I.I.C., S.A.	0	-5,672	9/30/2023
0 %	PT Asset Management AG	0	-1,800	9/30/2023
0 %	Neuberger Berman, LLC	0	-224	9/30/2023
0 %	Lannebo Fonder AB	0	-191,083	2/28/2023
0 %	Tredje AP Fonden	0	-300,000	12/31/2023
0 %	Amundi Ireland Limited	0	-143	7/31/2023
0 %	Nordea Funds Oy	0	-1,327	2/28/2023
0 %	PineBridge Investments Japan Co., Ltd.	0	-178	8/31/2022
0 %	Alfred Berg Kapitalförvaltning AB	0	-10,400	2/28/2023
0 %	FIL Investment Management (Hong Kong) Limited	0	-1,589	10/31/2022
0 %	Baillie Gifford & Co.	0	-28,318	4/30/2023
0 %	Jupiter Asset Management Ltd.	0	-1,852	9/30/2022
0 %	Baring Asset Management Ltd.	0	-26,487	9/30/2022
0 %	Fidelity International	0	-14,049	10/31/2022
0 %	Robeco Institutional Asset Management B.V.	0	-2,187	4/30/2023
0 %	Mackenzie Financial Corporation	0	-1,800	9/30/2023
0 %	Lazard Asset Management, L.L.C.	0	-294	4/30/2023

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Emergent BioSolutions	SupplierCustomer	0,72	0,64	0,68	-0,06	0,40	-0,76
Krystal Biotech	SupplierCustomer	0,50	0,72	0,77	0,70	-0,30	0,32
Celcuity	SupplierCustomer	0,45	0,62	0,35	-0,06	0,56	0,56
Beam Therapeutics	SupplierCustomer	0,44	0,84	0,31	-0,01	0,62	0,64
Showa Denko	SupplierCustomer	0,41	0,52	0,09	-	0,40	0,50
Roche Holding	SupplierCustomer	-0,60	0,72	0,23	0,11	-0,08	0,64

What values and corporate philosophy does Chemometec A/S represent?

Chemometec A/S represents strong values and a clear corporate philosophy. The company prioritizes innovation, scientific excellence, and customer satisfaction. With a focus on providing advanced solutions for cell counting and analysis, Chemometec A/S is committed to delivering accurate, reliable, and user-friendly products. They strive to empower researchers and laboratories with cutting-edge technologies that enhance efficiency and productivity. By continuously investing in research and development, Chemometec A/S ensures that their customers have access to the latest advancements in cell analysis. With their commitment to quality and customer-centric approach, Chemometec A/S aims to be a trusted partner in the field of life sciences.

In which countries and regions is Chemometec A/S primarily present?

Chemometec A/S is primarily present in several countries and regions worldwide. The company operates in various regions, including Europe, North America, Asia-Pacific, and the Middle East. Some specific countries where Chemometec A/S has a significant presence are Denmark, the United States, China, Germany, India, Japan, and many others. With its global reach, Chemometec A/S aims to serve customers and expand its market presence across different economies.

What significant milestones has the company Chemometec A/S achieved?

Some significant milestones achieved by Chemometec A/S include the development and commercialization of their flagship product, the NucleoCounter® system, which revolutionized cell counting and viability analysis in life science research and industry. The company also expanded its product portfolio with the introduction of the NucleoCassette™ and NucleoView™ software, enhancing the efficiency and accuracy of cell analysis further. Chemometec A/S successfully established a global presence, with offices and distributors in key markets worldwide, consolidating its position as a leading provider of innovative solutions for cell analysis. Through continuous investment in research and development, the company continues to deliver groundbreaking technologies to support scientific advancements.

What is the history and background of the company Chemometec A/S?

Chemometec A/S is a Danish biotechnology company founded in 1997. With headquarters in Allerød, Denmark, the company specializes in developing and manufacturing innovative instruments and software solutions for cell counting and analysis. Chemometec A/S has established itself as a leading provider of automated cell counters, offering high-quality and reliable products to the global scientific community. The company has garnered significant recognition for its unique imaging technology and advanced image analysis algorithms. Over the years, Chemometec A/S has expanded its product portfolio, ensuring accurate cell counting and viability assessment, particularly in the fields of hematology, microbiology, and life sciences.

Who are the main competitors of Chemometec A/S in the market?

The main competitors of Chemometec A/S in the market are Beckman Coulter, Inc., Sysmex Corporation, and Becton, Dickinson and Company.

In which industries is Chemometec A/S primarily active?

Chemometec A/S is primarily active in the biotechnology and life sciences industries.

What is the business model of Chemometec A/S?

The business model of Chemometec A/S is focused on providing advanced solutions for cellular analysis and diagnostics. The company specializes in developing and manufacturing instruments that enable users to quantify and analyze cells for various purposes, such as cell counting, size measurement, viability assessment, and cell cycle analysis. Chemometec A/S's innovative technologies and products cater to a wide range of industries, including biopharmaceuticals, life sciences research, clinical diagnostics, and industrial manufacturing. With a strong emphasis on accuracy, reliability, and user-friendliness, Chemometec A/S aims to support its customers in improving their research outcomes and diagnostic capabilities.

What is the P/E ratio of Chemometec A/S 2024?

The Chemometec A/S P/E ratio is 43.27.

What is the P/S ratio of Chemometec A/S 2024?

The Chemometec A/S P/S ratio is 16.02.

What is the AlleAktien quality score of Chemometec A/S?

The AlleAktien quality score for Chemometec A/S is 9/10.

What is the revenue of Chemometec A/S 2024?

The expected Chemometec A/S revenue is 436.72 M DKK.

How high is the profit of Chemometec A/S 2024?

The expected Chemometec A/S profit is 161.68 M DKK.

What is the business model of Chemometec A/S

Chemometec A/S is a Danish biotech company that offers innovative solutions and products for cell analysis in the fields of Hematology, Oncology, and Stem Cell Research. Their core product is the NucleoCounter platform, which includes automated cell counters with patented technology for precise counting and sizing of cells. The company serves various customers, including research institutions, clinical labs, hospitals, biotech and pharma companies, and contract research organizations. They aim to provide solutions that help customers achieve their scientific and clinical goals faster, more reliably, and at a lower cost.

What is the Chemometec A/S dividend?

Chemometec A/S pays a dividend of 0 DKK distributed over payouts per year.

How often does Chemometec A/S pay dividends?

The dividend cannot currently be calculated for Chemometec A/S or the company does not pay out a dividend.

What is the Chemometec A/S ISIN?

The ISIN of Chemometec A/S is DK0060055861.

What is the Chemometec A/S WKN?

The WKN of Chemometec A/S is A0MS80.

What is the Chemometec A/S ticker?

The ticker of Chemometec A/S is CHEMM.CO.

How much dividend does Chemometec A/S pay?

Over the past 12 months, Chemometec A/S paid a dividend of 6 DKK . This corresponds to a dividend yield of about 1.49 %. For the coming 12 months, Chemometec A/S is expected to pay a dividend of 2.41 DKK.

What is the dividend yield of Chemometec A/S?

The current dividend yield of Chemometec A/S is 1.49 %.

When does Chemometec A/S pay dividends?

Chemometec A/S pays a quarterly dividend. This is distributed in the months of February, November, November, November.

How secure is the dividend of Chemometec A/S?

Chemometec A/S paid dividends every year for the past 4 years.

What is the dividend of Chemometec A/S?

For the upcoming 12 months, dividends amounting to 2.41 DKK are expected. This corresponds to a dividend yield of 0.6 %.

In which sector is Chemometec A/S located?

Chemometec A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chemometec A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chemometec A/S from 10/17/2023 amounting to 6 DKK, you needed to have the stock in your portfolio before the ex-date on 10/13/2023.

When did Chemometec A/S pay the last dividend?

The last dividend was paid out on 10/17/2023.

What was the dividend of Chemometec A/S in the year 2023?

In the year 2023, Chemometec A/S distributed 0 DKK as dividends.

In which currency does Chemometec A/S pay out the dividend?

The dividends of Chemometec A/S are distributed in DKK.

Scope 1 - Direct Emissions	—
Scope 2 - Indirect emissions from purchased energy	—
Scope 3 - Indirect emissions within the value chain	—
Total CO₂ emissions	—
CO₂ reduction strategy	✅
Coal energy	❌
Nuclear power	❌
Animal experiments	❌
Fur & Leather	—
Pesticides	—
Palm Oil	—
Tobacco	❌
Genetically modified organisms	❌
Climate concept	—
Sustainable forestry	—
Recycling regulations	❌
Environmentally friendly packaging	❌
Hazardous substances	❌
Fuel consumption and efficiency	❌
Water consumption and efficiency	❌

Percentage of female employees	—
Percentage of women in management	—
Percentage of Asian employees	—
Share of Asian management	—
Percentage of Hispanic/Latino employees	—
Hispano/Latino Management share	—
Percentage of Black employees	—
Black Management Share	—
Percentage of white employees	—
White Management Share	—
Adult content	❌
Alcohol	❌
Weapons	—
Firearms	❌
Gambling	❌
Military contracts	❌
Human rights concept	❌
Privacy concept	—
Occupational health and safety	❌
Catholic	✅

Environmental reporting	❌
Stakeholder Engagement	❌
Call Back Policies	❌
Antitrust law	❌

Stock Exchange	Chemometec A/S Ticker
COPENHAGEN	CHEMM.CO
COPENHAGEN	CHEMM.CO
DÜSSELDORF	CHY.DU
FRANKFURT	CHY.F
LONDON	0DZ0.L
MUNICH	CHY.MU

Chemometec A/S Ticker	Chemometec A/S FIGI
CHEMM:DC	BBG000R59D46
CHEMMEUR:EO	BBG000RHV1F9
CHEMMEUR:E1	BBG000RHV7Q4
CHEMMEUR:XT	BBG000RHV873
CHEMMEUR:XW	BBG000RHV8H2
CHEMM:EO	BBG000RY1496
CHEMM:XH	BBG000RY15D8
CHEMM:XC	BBG000RY15Y5
CHEMM:XF	BBG000RY1637
CHEMM:XE	BBG000RY16Z2
CHEMM:XJ	BBG000RY1799
CHEMM:XL	BBG000RY17S8
CHEMM:XG	BBG000RY1851
CHEMM:XO	BBG000RY18S6
CHEMM:XS	BBG000RY1B81
CHEMM:XA	BBG000RY1BK7
CHEMM:E1	BBG000RY1BR0
CHEMM:XT	BBG000RY1BT8
CHEMM:XW	BBG000RY1C61
CHEMM:EU	BBG000RY1CP0
CHEMMEUR:EU	BBG000S72B97
CHEMMC:IX	BBG002KFMT56
CHEMMC:EB	BBG0058Q9379
CHEMMEUR:XV	BBG00591BF91
CHEMM:XV	BBG00591KW12
CHEMMC:TQ	BBG006BH1W86
CHEMMC:B3	BBG006T6LFV0
CHEMMC:L3	BBG006T9WXG0
CHEMMC:PO	BBG008GZGFP9
CHEMMC:BQ	BBG00CWYYV52
CHEMMEUR:XX	BBG00JN78231
CHEMM:XX	BBG00JN7HHT0
CHY:GR	BBG00N8DVTP7
CHY:GF	BBG00N8DVTQ6
CHY:GD	BBG00N8DVTR5
CHY:GS	BBG00N8DVTT3
CHY:GM	BBG00N8DVTV0
CHY:GB	BBG00N8DVTW9
CHEMMC:S1	BBG00NF079K3
CHEMMC:T1	BBG00NLK3Y58
CHEMMC:I2	BBG00NQBKXY4
CHEMM:X2	BBG00Q6R5WD6
0DZ0:LO	BBG00SY6K4D2
CHEMMC:L1	BBG00Y7BM8L8
CHEMMC:S4	BBG00YJ87W54
CHEMMGBP:XS	BBG00Z6QMVD1
CHEMMGBP:XH	BBG00Z6QMVH7
CHEMMGBP:XF	BBG00Z6QMVK3
CHEMMGBP:XE	BBG00Z6QMVM1
CHEMMGBP:XL	BBG00Z6QMVP8
CHEMMGBP:XG	BBG00Z6QMVQ7
CHEMMGBP:XO	BBG00Z6QMVR6
CHEMMGBP:XA	BBG00Z6QMVW0
CHEMMGBP:XT	BBG00Z6QMVY8
CHEMMGBP:XW	BBG00Z6QMVZ7
CHEMMGBP:XU	BBG00Z6QMW03
CHEMMGBP:XV	BBG00Z6QMW21
CHEMMGBP:XM	BBG00Z6QMW30
CHEMMGBP:EU	BBG00Z6QMWC0
CHY:TH	BBG00ZJYRYT2
CHY:GZ	BBG00ZKFXS17
CHY:QT	BBG00ZLGBW73
CHEMMC:QX	BBG016DVB3C0
CHEMMC:QE	BBG016DVFHM4
CHY:LA	BBG018H9P0J5
CHY:LU	BBG018J3BK98

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
13	14	22	44	32	32	37	39	41	45	61	85	90	112	175	214	281	428	444	436	454	467
-	7.69	57.14	100.00	-27.27	-	15.63	5.41	5.13	9.76	35.56	39.34	5.88	24.44	56.25	22.29	31.31	52.31	3.74	-1.80	4.13	2.86
53.85	57.14	54.55	70.45	59.38	65.63	67.57	66.67	65.85	64.44	62.30	64.71	66.67	70.54	76.57	78.50	81.49	79.91	78.83	-	-	-
7	8	12	31	19	21	25	26	27	29	38	55	60	79	134	168	229	342	350	0	0	0
0	0	1	14	2	-1	0	-11	1	1	5	15	10	24	54	77	116	202	230	208	197	192
-	-	4.55	31.82	6.25	-3.13	-	-28.21	2.44	2.22	8.20	17.65	11.11	21.43	30.86	35.98	41.28	47.20	51.80	47.71	43.39	41.11
-1	4	1	13	4	-3	0	-9	0	1	7	10	7	18	41	59	88	159	178	161	156	154
-	-500.00	-75.00	1,200.00	-69.23	-175.00	-	-	-	-	600.00	42.86	-30.00	157.14	127.78	43.90	49.15	80.68	11.95	-9.55	-3.11	-1.28
17	17	16.2	17.4	17.4	17.4	17.4	17.4	17.4	17.4	15.67	15.67	15.67	15.52	15.56	16.86	17.4	17.4	17.4	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

TickerCHEMM.CO

ISINDK0060055861

WKNA0MS80

Chemometec A/S stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Chemometec A/S Stock Price History

Chemometec A/S Revenue, EBIT, Net Income DK0060055861 · A0MS80

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Chemometec A/S Revenue, EBIT and net profit per share

Chemometec A/S Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Chemometec A/S stock margins DK0060055861 · A0MS80

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Chemometec A/S Margin History

Chemometec A/S Stock Sales Revenue, EBIT, Earnings per Share DK0060055861 · A0MS80

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Chemometec A/S Revenue, EBIT and net profit per share

Chemometec A/S business model

Chemometec A/S SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Chemometec A/S Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Chemometec A/S historical P/E ratio, EBIT, and P/S ratio.

Chemometec A/S shares outstanding DK0060055861 · A0MS80

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Chemometec A/S dividend history and estimates DK0060055861 · A0MS80

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Chemometec A/S Dividend History

Chemometec A/S dividend payout ratio DK0060055861 · A0MS80

Payout ratio

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
CHEMM.CO

ISIN
DK0060055861

WKN
A0MS80